Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(5):332; doi:10.1093/jnci/97.5.332
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Tuma, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuma, R. S.
Related Collections
Right arrowRelated News Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Multiple Gene Signatures Aim to Qualify Risk in Breast Cancer

Rabiya S. Tuma

The first 10% of the full text of this article appears below.

The Amsterdam signature is not the only gene panel that has been developed to predict breast cancer recurrence. Jan G. M. Klijn, M.D., Ph.D., and colleagues at Erasmus Medical Center in Rotterdam, the Netherlands, have identified a 76-gene signature that also identifies women at high and low risk of disease recurrence. Like the Amsterdam group, the Rotterdam group focused on women with node-negative disease, using . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related News Article in JNCI

Trial and Error: Prognostic Gene Signature Study Design Altered
Rabiya S. Tuma
J Natl Cancer Inst 2005 97: 331-333. [Extract] [Full Text] [PDF]